🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

54% of members evaluated in the recently released second edition of our Congressional Innovation Scorecard earned a 'C' or below. This means that a clear majority of Congress shows only a limited interest in advancing pro-IP legislation and policy. Learn more:

A 2006 court ruling too often lets patent thieves keep profiting, even after being caught. Congress can fix this. The RESTORE Patent Rights Act would reestablish injunctive relief as the default legal remedy for patent infringement. Learn more 👇 buff.ly/MdjEjvS

DYK that patent rights are guaranteed in the Constitution? "The Constitution gives Congress the right to create laws to protect inventors and authors and give them the 'exclusive right' … to their discoveries and writings." - C4IP Co-Chair and former @USPTO Director Andrei

❌ Myth: The Preserve Access to Affordable Generics and Biosimilars Act would "reduce drug prices by promoting competition." ✅ Fact: The bill would not meaningfully reduce drug prices -- but it would undermine the basic ability of patent holders to defend their inventions.

🎧 Listen to C4IP Co-Chair and former @USPTO Director David Kappos discuss the link between IP protections and innovation: "The role of intellectual property is to provide an incentive for creating new medicines in the first place."

DYK? China is currently outperforming the U.S. in the majority of cutting-edge technology fields, according to data from ASPI. America's global competitiveness relies on robust IP protections. To learn more about how we can fortify U.S. IP, check out our recently

"The existence of a patent quality crisis is contradicted by the data. In fact, a recent study… found that when it comes to weeding out inventions that should not be patented, the @USPTO is already world-class." - C4IP Co-Chairs & fmr. USPTO Directors Andrei Iancu & David

Honored to receive an A+ rating for my work defending intellectual property rights in Congress. Innovation is key to American strength. We must protect the ideas, inventions, and creators that drive our economy forward. Grateful to be recognized as the only House member to earn

"The 118th Congress largely failed to advance meaningful IP reform. The 119th Congress now has a unique opportunity to build on the positive steps taken over the past two years." For more info, check out the second edition of our Congressional Innovation Scorecard:

ICYMI: In a new piece for U.S. News & World Report, fmr. Chair of the DNC and Governor of Vermont Howard Dean argues that strong IP protections are essential for safeguarding the innovation necessary to combat future pandemics. Read our blog unpacking the piece ⬇️ buff.ly/k4iKLc2

📣 Check out this new op-ed from C4IP Board Member & former Federal Judge Paul Michel in Law360: "A weakened U.S. patent system makes it harder for American firms to out-innovate and out-compete foreign competitors … The RESTORE Patent Rights Act would fix the problem."

📰 In the news: a recent @IPWatchdog article highlighted some of the key takeaways from the second edition of our Congressional Innovation Scorecard. "Among the key findings of C4IP's scorecard is that a clear majority of Congress has only limited interest in advancing pro-IP

ICYMI: C4IP sent a letter to the European Commission raising serious concerns about proposed revisions to the EU's General Pharmaceutical Legislation and Patent Package. Read it here ⬇️ buff.ly/3FTbOyX

Myth: Drug companies' "gaming" of the patent system impedes access to generic medications and keeps prices high. Fact: Bemoaning a lack of generic competition discounts the reality that 9 in 10 U.S. prescriptions are filled with generics. When available, generics are dispensed

Check out this recent interview with C4IP Co-Chair and former USPTO Director David Kappos! Dir. Kappos discusses the state of innovation in Pennsylvania and Senator John Fetterman's 2025 Congressional Innovation Scorecard grade. Watch the segment ⬇️ buff.ly/mMiWNXg

"The fact is, without robust patent protections, we wouldn't have these life-changing drugs at all... Those who want to gut patent rights seem to think that groundbreaking medications materialize out of thin air." - C4IP Co-Chair and former USPTO Director David Kappos Learn

From cars to smartphones, nearly all companies in every industry eventually stop making or supporting earlier versions of their products. Few would see this as malicious. Next time you hear about so-called product hopping, remember that, in every other industry, we call this

📅 Mark your calendar for 6/25 from 11 AM - 12 PM ET! C4IP Co-Chair and fmr. USPTO Director Andrei Iancu will join a panel with other experts to discuss how academia, government, and industry all work together to drive U.S. innovation. Register for this National Academy of Inventors event:

Thank you to Council for Innovation Promotion for an A+ on their 2025 congressional scorecard! I will always fight for bipartisan solutions to protect intellectual property rights so that America's innovators can keep pushing us into the future.

ICYMI: Rep. Hank Johnson (D-GA) received an "A" on our 2025 Congressional Scorecard for his hard work on Capitol Hill to strengthen America's intellectual property ecosystem. Read his statement in response to the grade: buff.ly/OnOaCn4